Eric Bartee Selected Research

Aftercare (After-Treatment)

1/2019

Chimeric tumor modeling reveals role of partial PDL1 expression in resistance to virally induced immunotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eric Bartee Research Topics

Disease

22	Neoplasms (Cancer) 01/2023 - 09/2009
6	Infections 12/2020 - 07/2008
6	Myxoma (Myxomas) 01/2019 - 10/2012
4	Multiple Myeloma 04/2016 - 10/2012
2	Graft vs Host Disease (Graft-Versus-Host Disease) 11/2021 - 01/2012
2	Melanoma (Melanoma, Malignant) 12/2020 - 01/2017
2	Residual Neoplasm 01/2016 - 10/2012
2	Virus Diseases (Viral Diseases) 05/2012 - 09/2009
1	Squamous Cell Carcinoma of Head and Neck 01/2023
1	Bites and Stings (Sting) 01/2023
1	Ovarian Epithelial Carcinoma 09/2022
1	Ovarian Neoplasms (Ovarian Cancer) 09/2022
1	Inflammation (Inflammations) 01/2022
1	Vaccinia 01/2020
1	Hematologic Neoplasms (Hematological Malignancy) 01/2012
1	Necrosis 09/2009
1	Kaposi Sarcoma (Kaposi's Sarcoma) 09/2002
1	Leukemia 09/2002

Drug/Important Bio-Agent (IBA)

4	EnzymesIBA 01/2023 - 04/2016
4	Proteins (Proteins, Gene)FDA Link 01/2019 - 09/2002
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 07/2008
3	CytokinesIBA 01/2019 - 09/2009
2	Interleukin-12 (IL 12)IBA 01/2022 - 11/2021
2	Programmed Cell Death 1 ReceptorIBA 01/2020 - 01/2017
2	InterferonsIBA 09/2009 - 09/2009
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2023
1	Amino Acids FDA Link 01/2023
1	Argininosuccinate Synthase (Argininosuccinate Synthetase)IBA 01/2023
1	Aspartic Acid (Aspartate)FDA Link 01/2023
1	CitrullineIBA 01/2023
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2023
1	LuciferasesIBA 09/2022
1	Glucose (Dextrose)FDA LinkGeneric 09/2022
1	Interleukin-23 (Interleukin 23)IBA 11/2021
1	Interleukin-23 Subunit p19IBA 11/2021
1	PolyaminesIBA 10/2021
1	Eflornithine (Ornidyl)FDA Link 10/2021
1	GlycosaminoglycansIBA 12/2020
1	SulfotransferasesIBA 12/2020
1	Heparin (Liquaemin)FDA LinkGeneric 01/2020
1	Antigen Receptors (Antigen Receptor)IBA 01/2019
1	Interleukin-2 (IL2)IBA 01/2019
1	AntibodiesIBA 01/2017
1	Immune Checkpoint InhibitorsIBA 01/2017
1	Caspase 8 (Caspase-8)IBA 04/2016
1	Activating Transcription Factor 4IBA 01/2015
1	Transcription Factors (Transcription Factor)IBA 01/2015
1	Proteasome InhibitorsIBA 01/2015
1	Bortezomib (Velcade)FDA Link 01/2015
1	Complex MixturesIBA 10/2012
1	GenisteinIBA 06/2010
1	Tyrosine Kinase InhibitorsIBA 06/2010
1	Interferon-betaIBA 09/2009
1	Antiviral Agents (Antivirals)IBA 09/2009
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 07/2008
1	Interferon Type IIBA 07/2008
1	RNA (Ribonucleic Acid)IBA 07/2008
1	Histocompatibility Antigens Class IIBA 09/2002

Therapy/Procedure

10	Therapeutics 01/2022 - 10/2012
9	Oncolytic Virotherapy 01/2023 - 01/2012
5	Immunotherapy 01/2023 - 01/2019
2	Drug Therapy (Chemotherapy) 01/2016 - 01/2012
1	Aftercare (After-Treatment) 01/2019
1	Stem Cell Transplantation 10/2012
1	Transplantation 01/2012